| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 9.972 | 11.068 | 9.618 | 15.060 | 19.625 | 14.474 | 15.847 | 13.409 | 22.211 | 25.564 |
| Total Income - EUR | 10.036 | 11.074 | 12.369 | 15.060 | 19.625 | 14.474 | 15.861 | 13.409 | 22.211 | 45.898 |
| Total Expenses - EUR | 14.461 | 13.989 | 19.551 | 14.575 | 12.595 | 10.909 | 12.810 | 15.188 | 17.812 | 41.472 |
| Gross Profit/Loss - EUR | -4.424 | -2.915 | -7.182 | 484 | 7.030 | 3.565 | 3.051 | -1.779 | 4.400 | 4.426 |
| Net Profit/Loss - EUR | -4.424 | -3.136 | -7.279 | 334 | 6.834 | 3.433 | 2.892 | -1.913 | 4.177 | 4.096 |
| Employees | 2 | 2 | 2 | 2 | 1 | 2 | 3 | 2 | 2 | 2 |
Check the financial reports for the company - Cocomed 7 Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 1.809 | 1.669 | 820 | 575 | 479 | 386 | 1.167 | 1.017 | 861 | 1.098 |
| Current Assets | 10.337 | 7.575 | 4.886 | 11.066 | 10.979 | 8.015 | 7.530 | 9.571 | 12.766 | 13.853 |
| Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 4.224 | 3.373 | 2.290 | 1.076 | 3.275 | 2.131 | 1.502 | 3.236 | 2.071 | 631 |
| Cash | 6.113 | 4.202 | 2.596 | 9.990 | 7.704 | 5.883 | 6.027 | 6.336 | 10.695 | 13.221 |
| Shareholders Funds | -8.650 | -11.295 | -18.727 | -18.072 | -10.888 | -7.249 | -4.195 | -6.121 | -1.925 | 2.181 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 20.796 | 20.538 | 24.433 | 29.713 | 22.345 | 15.649 | 12.892 | 16.710 | 15.552 | 12.770 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "7020 - 7020" | |||||||||
| CAEN Financial Year |
7022
|
|||||||||
Comments - Cocomed 7 Srl